Related Experiment Video

Updated: Oct 12, 2025

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
08:15

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System

Published on: April 11, 2025

504

Genetic Regulation of RIPK1 and Necroptosis

Daichao Xu1, Chengyu Zou1, Junying Yuan1

  • 1Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China;

Annual Review of Genetics
|November 23, 2021
PubMed

Insights

Receptor-interacting protein kinase 1 (RIPK1) regulates cell death and inflammation. Genetic insights into RIPK1

Area of Science:

  • Cellular Biology
  • Immunology
  • Genetics

Background:

  • Receptor-interacting protein kinase 1 (RIPK1) is a key regulator of cell survival, inflammatory signaling, and cell death pathways like apoptosis and necroptosis.
  • RIPK1 kinase activation is modulated by ubiquitination and phosphorylation, influencing the NF-κB pathway.
  • Genetic factors control RIPK1 activation and its interactions with downstream effectors, including caspase-8 and RIPK3.

Purpose of the Study:

  • To review current findings on the genetic modulation of RIPK1.
  • To discuss the role of RIPK1 in human autoinflammatory conditions.
  • To explore therapeutic strategies targeting RIPK1 for inflammatory and neurodegenerative diseases.

Main Methods:

  • Literature review of genetic and mechanistic studies on RIPK1.
  • Analysis of RIPK1's role in apoptosis and necroptosis.
  • Examination of genetic autoinflammatory diseases linked to RIPK1.

Main Results:

  • Genetic modulation significantly impacts RIPK1 activation and its downstream signaling.
  • Abnormal RIPK1 activation is implicated in human autoinflammatory conditions.
  • RIPK1 interacts with caspase-8 and RIPK3 to mediate cell death.

Conclusions:

  • Understanding RIPK1's genetic and mechanistic roles is crucial.
  • Targeting RIPK1 offers potential therapeutic avenues for inflammatory and neurodegenerative diseases.
  • Further research into RIPK1 biology can advance treatment strategies.
Keywords:
MLKLRIPK1RIPK3TNFR1apoptosisinflammationnecroptosisneurodegeneration

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.0K
Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.4K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K